The role of glycemia in acute heart failure patients

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 10, 2014, Pages 1437-1446

  Seferović, Jelena P ^b   Milinković, Ivan ^c   Tešić, Milorad ^c   Ristić, Arsen ^c   Lalić, Nebojša ^c   Simeunović, Dejan ^c   Živković, Ivana ^b   Di Somma, Salvatore ^c   Seferovic, Petar M ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Acute heart failure; Diabetes; Mortality; Prevalence

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; HUMAN; HYPERGLYCEMIA; MORBIDITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ACUTE DISEASE; BLOOD; COMPLICATION; DIABETES COMPLICATIONS; GLUCOSE BLOOD LEVEL; HEART FAILURE; METABOLISM;

GLUCOSE BLOOD LEVEL;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; BLOOD GLUCOSE; COMORBIDITY; DIABETES COMPLICATIONS; HEART FAILURE; HUMANS;

EID: 84921382237     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0239     Document Type: Review

References (96)

1. Gheorghiade M, Zannad F, Sopko G, Klein L, Pina IL, Konstam MA, et al. Acute heart failure syndromes: current state and framework for future research. Circulation 2005;112:3958-68.
2. O'Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M. Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. J Card Fail 2005;11:200-5.
3. Parissis JT, Rafouli-Stergiou P, Mebazaa A, Ikonomidis I, Bistola V, Nikolaou M, et al. Acute heart failure in patients with diabetes mellitus: clinical characteristics and predictors of in-hospital mortality. Int J Cardiol 2012;157:108-13.
4. Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol 2008;52:428-34.
5. Follath F, Yilmaz MB, Delgado JF, Parissis JT, Porcher R, Gayat E, et al. Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARMHF). Int Care Med 2011;37:619-26.
6. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006;27:2725-36.
7. Wass CI, Lanier WL. Glucose modulation of ischemic brain injury: review and clinical recommendations. Mayo Clin Proc 1996;71:801-12.
8. Smith ML, von Hanwehr R, Siesjo BK. Changes in extra- and intracellular pH in the brain during and following ischemia in hyperglycemic and in moderately hypoglycemic rats. J Cereb Flow Metab 1986;6:574-83.
9. Kaukinen S, Salmi J, Marttinen A, Koivula T. Postoperative hyperglycemia: are the patients diabetic? Exp Clin Endocrinol 1992;100:85-9.
10. Siegel JH, Cerra FB, Coleman B, Giovannini I, Shetye M, Border JR, et al. Psychological and metabolic correlation in human sepsis. Surgery 1979;86:163-93.
11. Ceriello A. The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia 2003;46(Suppl 1):M9-16.
12. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 2005;54:1-7.
13. Ceriello A, Quagliaro L, Catone B, Pascon R, Piazzola M, Bais B, et al. Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care 2002;25:1439-43.
14. Aguilar D, Bozkurt B, Ramasubbu K, Deswal A. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol 2009;54:422-8.
15. Mebazaa A, Gayat E, Lassus J, Meas T, Mueller C, Maggioni A, et al; GREAT Network. Association between elevated blood glucose and outcome in acute heart failure. JACC 2013;61: 820-9.
16. Greenberg BH, Abraham WT, Albert NM, Chiswell K, Clare R, Stough WG, et al. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 2007;154:277.e1-8.
17. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209-16.
18. Stratton IM, Alder AI, Neil HA, Matthews DR, Maneley SE, Cull CA, et al; UK Prospective Diabetes Study Group. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). Br Med J 2000;321:405-12.
19. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes. Diabetologia 2001;44:2107-14.
20. Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D, et al; International Prandial Glucose Regulation (PGR) Study Group. Postprandial glucose regulation and diabetic complications. Arch Intern Med 2004;164:2090-5.
21. Mizok BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 1995;98:75-84.
22. Rodriguez B, McNeill JH. The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 1992;26:913-22.
23. Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 2004;10:248-54.
24. Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 2008;121:748-57.
25. Chiu J, Farhangkhoee H, Xu BY, Chen S, George B, Chakrabarti S. PARP mediates structural alterations in diabetic cardiomyopathy. J Mol Cell Cardiol 2008;45:385-93.
26. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, et al. Myocardial cell death in human diabetes. Circ Res 2000;87:1123-32.
27. Chen S, Evans T, Mukherjee K, Karmazyn M, Chakrabarti S. Diabetes- induced myocardial structural changes: role of endothelin- 1 and its receptors. J Mol Cell Cardiol 2000;32:1621-9.
28. Fischer VW, Barner HB, Larose LS. Pathomorphologic aspects of muscular tissue in diabetes mellitus. Hum Pathol 1984;15: 1127-36.
29. Zieman SJ, Kass DA. Advanced glycation end-product crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease. Drugs. 2004;64:459-70.
30. Rodrigues B, Cam MC, McNeill JH. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem 1998;180:53-7.
31. Eckel J, Reinauer H. Insulin action on glucose transport in isolated cardiac myocytes: signalling pathways and diabetesinduced alterations. Biochem Soc Trans 1990;18:1125-7.
32. Liedtke AJ, DeMaison L, Eggleston AM, Cohen LM, Nellis SH. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res 1988;62:535-42.
33. Yazaki Y, Isobe M, Takahashi W Kitabayashi H, Nishiyama O, Sekiguchi M, et al. Assessment of myocardial fatty acid abnormalities in patients with idiopathic dilated cardiomyopathy using I123 BMIPP SPECT: correlation with clinicopathological findings and clinical course. Heart 1999;81:153-9.
34. Malhotra A, Sanghi V. Regulation of contractile proteins in diabetic heart. Cardiovasc Res 1997;34:34-40.
35. Takeda N, Nakamura I, Hatanaka T, Ohkubo T, Nagano M. Myocardial mechanical and myosin isoenzyme alterations in streptozotocin-diabetic rats. Jpn Heart J 1988;29:455-63.
36. Abe T, Ohga Y, Tabayashi N, Kobayashi S, Sakata S, Misawa H. Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats. Am J Physiol Heart Circ Physiol 2002;282:H138-48.
37. Murray AJ, Anderson RE, Watson GC, Radda GK, Clarke K. Uncoupling proteins in human heart. Lancet 2004;364:1786-8.
38. Swan JW, Anker SD, Walton C, Godsland IF, Clark AL, Leyva F, et al. Insulin resistance in chronic failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 1997;30:527-32.
39. Kajstura J, Fiordaliso F, Andreoli AM, Li B, Chimenti S, Medow MS, et al. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 2001;50:1414-24.
40. MacDonald MR, Petrie MC, Hawkins NM, Petrie JR, Fisher M, McKelvie R, et al. Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J 2008;29:1224-40.
41. Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol 2001;38:421-8.
42. Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, et al. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol 2003;42:914-22.
43. Shindler DM, Kostis JB, Yusuf S, Quinones MA, Pitt B, Stewart D, et al. Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registry. Am J Cardiol 1996;77:1017-20.
44. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. J Am Med Assoc 2003;290:2581-7.
45. Shekelle PG, Rich MW, Morton SC, Atkinson CS, Tu W, Maglione M, et al. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol 2003;41:1529-38.
46. Haas SJ, Vos T, Gilbert RE, Krum H. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. Am Heart J 2003;146:848-53.
47. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KW, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2005;27:65-75.
48. Smooke S, Horwich TB, Fonarow GC. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure. Am Heart J 2005;149:168-74.
49. Gustafsson I, Brendorp B, Seibaek M, Burchardt H, Hildebrandt P, Køber L, et al. Influence of diabetes and diabetes gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 2004;43:771-7.
50. Lee R, Chan SP, Wong J, Lau D, Ho KT, Kenneth NG. Impact of diabetes mellitus on survival in South East Asian patients with congestive heart failure due to left ventricular systolic dysfunction. Int J Cardiol 2010;142:97-100.
51. Brophy JM, Dagenais GR, McSherry F, Williford W, Yusuf S. A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction. Am J Med 2004;116: 300-4.
52. Subramanian U, Kamalesh M, Temkit M, Eckert GJ, Sawada S. Do cardioselective beta adrenoceptor antagonists reduce mortality in diabetic patients with congestive heart failure? Am J Cardiovasc Drugs 2009;9:231-40.
53. Newton JD, Squire IB. Glucose and haemoglobin in the assessment of prognosis after first hospitalization for heart failure. Heart 2006;92:1441-6.
54. Barsheshet A, Garty M, Grossman E, Sandach A, Lewis BS, Gottlieb S, et al. Admission blood glucose level and mortality among hospitalized non-diabetic patients with heart failure. Arch Intern Med 2006;166:1613-9.
55. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC; for the ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the acute decompensated heart failure national registry ADHERE database. J Am Coll Cardiol 2006;47:76-84.
56. Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure. J Am Coll Cardiol 2008;52:347-56.
57. Harjola VP, Follath F, Nieminen MS, Brutsaert D, Dickstein K, Drexler H, et al. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. Eur J Heart Fail 2010;12:239-48.
58. Gilbert EH, Lowenstein SR, Koziol-McLain J, Barta DC, Steiner J. Chart reviews in emergency medicine research: where are the methods? Ann Emerg Med 1996;27:305-8.
59. Januzzi JL Jr., Rehman S, Mueller T, van Kimmenade RR, Lloyd-Jones DM. Importance of biomarkers for long-term mortality prediction in acutely dyspneic patients. Clin Chem 2010;56:1814-21.
60. Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L, et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. J Am Med Assoc 2009;301:1556-64.
61. Loomba RS, Arora R. Hyperglycemia and acute coronary syndrome: a systematic review of hyperglycemia's impact on ACS. Am J Ther 2010;17:e48-51.
62. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, et al., American heart association diabetes committee of the council on nutrition, physical activity and metabolism. hyperglycemia and acute coronary syndrome: a scientific statement from the american heart association diabetes committee of the council on nutrition, Physical Activity, and Metabolism. Circulation 2008;117:1610-9.
63. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005;111:3078-86.
64. Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 2008;117:1018-27.
65. Lazzeri C, Chiostri M, Sori A, Valente S, Gensini GF. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement. J Cardiovasc Med (Hagerstown) 2010;11:7-13.
66. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2 year all cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 2005;26:1255-61.
67. Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 2006;27:1289-97.
68. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005;111:754-60.
69. Valente S, Lazzeri C, Vecchio S, Giglioli C, Margheri M, Bernardo P, et al. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol 2007;114:176-82.
70. Vis MM, Sjauw KD, van der Schaaf RJ, Baan J Jr, Koch KT, DeVries JH, et al. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes. Am Heart J 2007;154:1184-90.
71. Pres D, Gasior M, Strojek K, Gierlotka M, Hawranek M, Lekston A, et al. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention. Kardiol Pol 2010;68:743-51.
72. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;55:773-8.
73. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycemia an independent predictor of poor outcome after acute stroke? Results from a long term follow up study. Br Med J 1997;314:1303-6.
74. Malmberg K for the DIGAMI Study Group. Prospective randomised study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. Br Med J 2007;314:1512-5.
75. Nishio K, Shigemitsu M, Kusuyama T, Fukui T, Kawamura K, Itoh S, et al. Insulin resistance in nondiabetic patients with acute myocardial infarction. Cardiovasc Revasc Med 2006;7:54-60.
76. Wallander M, Bartnik M, Efendic S. Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study. Diabetologia 2005;48:2229-35.
77. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 1986;293:917-22.
78. Tansey MJ, Opie LH. Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction. Lancet 1983;2:419-22.
79. Dandona P, Aljada A, Bandyopadhyay A. The potential therapeutic role of insulin in acute myocardial infarction in patients admitted to intensive care and in those with unspecified hyperglycemia. Diabetes Care 2003;26:516-9.
80. Lazzeri C, Sori A, Chiostri M, Picariello C, Gensini GF, Valente S. Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. Eur J Anaesthesiol 2009;26:856-62.
81. Caccamo G, Bonura F, Bonura F, Vitale G, Novo G, Evola S, et al. Insulin resistance and acute coronary syndrome. Atherosclerosis 2010;211:672-5.
82. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003;88:1082-8.
83. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest 1994;94:1172-9.
84. Lazzeri C, Valente S, Attanà P, Chiostri M, Picariello C, Gensini GF. Acute hyperglycemia and insulin resistance in acute heart failure syndromes without previously known diabetes. Intern Emerg Med 2012;7:497-503.
85. Kosiborod M, Inzucchi SE, Spertus JA, Wang Y, Masoudi FA, Havranek EP, et al. Elevated admission glucose and mortality in elderly patients hospitalized with heart failure. Circulation 2009;119:1899-907.
86. Novack V, Pencina M, Zahger D, Fuchs L, Nevzorov R, Jotkowitz A, et al. Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute decompensated heart failure. PLoS One5 2010;(8):e12184.
87. Falciglia M, Freyberg RW, Almenoff PL, D'Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 2009;37:3001-9.
88. Tenerz A, Norhammar A, Silveira A, Hamsten A, Nilsson G, Ryden L, et al. Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 2003;26:2770-6.
89. Diaz R, Goyal A, Mehta SR, Afzal R, Xavier D, Pais P, et al. Glucose-insulin-potassium therapy in patients with STsegment elevation myocardial infarction. J Am Med Assoc 2007;298:2399-405.
90. Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L, Anderson C, et al.; for the ONTARGET/TRANSCEND Investigators. Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation 2007;115:1371-5.
91. Thrainsdottir IS, Aspelund T, Hardarson T, Malmberg K. Sigurdsson G, Thorgeirsson G, et al. Glucose abnormalities and heart failure predict poor prognosis in the population-based Reykjavik Study. Eur J Cardiovasc Prev Rehabil 2005;12:465-71.
92. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: a meta regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-40.
93. Asia Pacific Cohort Studies Collaboration. Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care 2004;27:2836-42.
94. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia is an independent marker of inpatient mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978-82.
95. Kragelund C, Snorgaard O, Kober L, Bengtsson B, Ottesen M, Hojberg S, et al. Hyperinsulinaemia is associated with increased long-term mortality following acute myocardial infarction in non-diabetic patients. Eur Heart J 2004;25:1891-7.
96. Oswald GA, Smith CC, Delamothe AP, Betteridge DJ, Yudkin JS. Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction. Br Heart J 1988;59:663-71.